A Pharmaceuticals and Healthcare ( Bulk Drug manufacturing ) entity from India is looking to raise strategic funding.
BUSINESS BRIEF
Pharma company in the field of manufacturing APIs for Therapeutic drugs and Intermediates, R&D, Custom Synthesis is looking to raise funds to restart its operations. The firm has always focused on complicated chemistries and specialty products and manufactures various Therapeutic drugs including Anti-Parkinson, Anti-Ulcerative, Anti-Asthmatic, Anti Bacterial, etc. The firm has 2 units and to set up a second plant for which they took a loan from Bank but did not get the clearance due to the vested interest of the local government. It took 26 months to get clearance from the Local government. At the same time, an untimely separate state agitation happened and non-co-operation from banks led to the company becoming NPA. That's why sales are 0.
Proposal
 Capital Requirement
|
INR 350 to 400 Mn |
| Justification: The firm has large domestic and international clients including Pfizer, Ranbaxy, Dr. Reddy, etc. | |
|
Funding Route
Private Equity, Strategic Investor |
Extent Of Dilution
Upto 49 % |
|
Share Holding Pattern
Promoter Group 100% Non-Promoter Share Holder 0% |
Reason For Raising Capital
Reduce Leverage, |
| Entity is open for Investor keen on special situation/distress assets funding. | |
Business Operating Information
Industry
Pharmaceuticals and Healthcare
Sub-Industry
Bulk Drug manufacturing
Division
Division`s Market Share
Not Disclosed
Division`s Growth rate in 3 years
Not Disclosed
Division`s Key Partnership`s
Not Disclosed
Division`s Buyers/Customers
Division`s Plant Location
Division`s Products/Services
Market Share %
Not Disclosed
Growth rate in 3 years
Not Disclosed
Key Partnerships
Not Disclosed
Division`s Products/Services
Market Share %
Not Disclosed
Growth rate in 3 years
Not Disclosed
Key Partnerships
Not Disclosed
Division`s Products/Services
Market Share %
Not Disclosed
Growth rate in 3 years
Not Disclosed
Key Partnerships
Not Disclosed
Business Strength
Rd strength
Justification n/a
Manufacturing strength
Justification n/a
Financial Information
| 2017 (in INR) | 2018 (in INR) | 2019 (in INR) | 2020 (in INR) | ||
|---|---|---|---|---|---|
| Sales | N.D | N.D | N.D | N.D | |
| EBDITA | N.D | N.D | N.D | N.D | |
| PAT | N.D | N.D | N.D | N.D | |
| TANGIBLE NET WORTH | N.D | N.D | N.D | N.D | |
| LONG TERM DEBT | N.D | N.D | N.D | N.D | |
| TOTAL DEBT | N.D | N.D | N.D | N.D | |
CONTACT BUSINESS
If you are interested in connecting with business please send an Expression of Interest.
EXPRESS INTEREST MARK FAVOURITESHARE VIA
CONTACT DETAILS
